M&A Deal Summary

Harmony Acquires Zynerba Pharmaceuticals

On August 14, 2023, Harmony acquired life science company Zynerba Pharmaceuticals for 200M USD

Acquisition Highlights
  • This is Harmony’s 1st transaction in the Life Science sector.
  • This is Harmony’s largest (disclosed) transaction.
  • This is Harmony’s 1st transaction in the United States.
  • This is Harmony’s 1st transaction in Pennsylvania.

M&A Deal Summary
Date 2023-08-14
Target Zynerba Pharmaceuticals
Sector Life Science
Buyer(s) Harmony
Deal Type Add-on Acquisition
Deal Value 200M USD
Advisor(s) MTS Health Partners LP (Financial)
Goodwin Procter (Legal)

Target

Zynerba Pharmaceuticals

Devon, Pennsylvania, United States
Zynerba Pharmaceuticals is a pharmaceutically-produced transdermal cannabinoid therapies for orphan neuropsychiatric disorders, including Fragile X syndrome (FXS). Zynerba Pharmaceuticals was founded in 2007 and is based in Devon, Pennsylvania.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Harmony

Plymouth Meeting, Pennsylvania, United States
Category Company
Founded 2017
Sector Life Science
Employees246
Revenue 582M USD (2023)
DESCRIPTION

Harmony is a biopharmaceutical company developing and commercializing innovative drugs to address unmet needs for patients with sleep and CNS disorders. Harmony was founded in 2017 and is based in Plymouth Meeting, Pennsylvania.

DEAL STATS #
Overall 1 of 2
Sector (Life Science) 1 of 2
Type (Add-on Acquisition) 1 of 2
State (Pennsylvania) 1 of 1
Country (United States) 1 of 2
Year (2023) 1 of 1
Size (of disclosed) 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2024-04-30 Epygenix Therapeutics

Paramus, New Jersey, United States

Epygenix Therapeutics is a precision medicine-based biopharmaceutical company focused on genetically screening, discovering, and developing drugs to treat rare and intractable forms of genetic epilepsy in childhood, such as Dravet syndrome (DS). Epygenix Therapeutics is based in Paramus, New Jersey.

Buy -
Mergr

Product

Company

Legal